Next Article in Journal
Notch Signaling in Pancreatic Development
Next Article in Special Issue
The Protective Effect of Icariin on Mitochondrial Transport and Distribution in Primary Hippocampal Neurons from 3× Tg-AD Mice
Previous Article in Journal
Effect of Greenhouse Gases Dissolved in Seawater
Previous Article in Special Issue
The Safety Evaluation of Salvianolic Acid B and Ginsenoside Rg1 Combination on Mice
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2016, 17(1), 47; doi:10.3390/ijms17010047

Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway

1
Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazzale Europa 1, Trieste 34128, Italy
2
Institute for Maternal and Child Health—IRCCS “Burlo Garofolo”, via dell’Istria, 65/1, Trieste 34137, Italy
3
Cluster in Biomedicine (CBM scrl), Trieste 34128, Italy
*
Author to whom correspondence should be addressed.
Academic Editors: Ge Zhang and Aiping Lu
Received: 17 November 2015 / Revised: 23 December 2015 / Accepted: 24 December 2015 / Published: 30 December 2015
View Full-Text   |   Download PDF [1195 KB, uploaded 30 December 2015]   |  

Abstract

The cholesterol pathway is an essential biochemical process aimed at the synthesis of bioactive molecules involved in multiple crucial cellular functions. The end products of this pathway are sterols, such as cholesterol, which are essential components of cell membranes, precursors of steroid hormones, bile acids and other molecules such as ubiquinone. Several diseases are caused by defects in this metabolic pathway: the most severe forms of which cause neurological involvement (psychomotor retardation and cerebellar ataxia) as a result of a variety of cellular impairments, including mitochondrial dysfunction. These pathologies are induced by convergent mechanisms in which the mitochondrial unit plays a pivotal role contributing to defective apoptosis, autophagy and mitophagy processes. Unraveling these mechanisms would contribute to the development of effective drug treatments for these disorders. In addition, the development of biochemical models could have a substantial impact on the understanding of the mechanism of action of drugs that act on this pathway in multifactor disorders. In this review we will focus in particular on inhibitors of cholesterol synthesis, mitochondria-targeted drugs and inhibitors of the inflammasome. View Full-Text
Keywords: cholesterol; mitochondria; apoptosis; autophagy; inflammasome cholesterol; mitochondria; apoptosis; autophagy; inflammasome
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Marcuzzi, A.; Piscianz, E.; Loganes, C.; Vecchi Brumatti, L.; Knowles, A.; Bilel, S.; Tommasini, A.; Bortul, R.; Zweyer, M. Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway. Int. J. Mol. Sci. 2016, 17, 47.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top